Cost-effectiveness analysis of initial treatment strategies for mild-to-moderate Clostridium difficile infection in hospitalized patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost-effectiveness analysis of initial treatment strategies for mild-to-moderate Clostridium difficile infection in hospitalized patients

Published:2018-08-01 Issue:15 Volume:75 Page:1110-1121
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Ford Diana C.¹,Schroeder Mary C.²,Ince Dilek³,Ernst Erika J.²

Affiliation:

1. Department of Pharmaceutical Care, University of Iowa Hospitals and Clinics, Iowa City, IA

2. Division of Health Services Research, University of Iowa College of Pharmacy, Iowa City, IA

3. Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/75/15/1110/28841712/ajhp1110.pdf

Reference41 articles.

1. Current trends in the epidemiology and outcomes of Clostridium difficile infection;Evans;Clin Infect Dis,2015

2. Burden of Clostridium difficile infection in the United States;Lessa;N Engl J Med,2015

3. The morbidity, mortality, and costs associated with Clostridium difficile infection;Kwon;Infect Dis Clin North Am,2015

4. The economic burden of Clostridium difficile;McGlone;Clin Microbiol Infect,2012

5. Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review;Gabriel;J Hosp Infect,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults;Clinical Microbiology and Infection;2021-12

2. Recent Advances in Clinical Utility of Probiotics in Gastrointestinal Tract Disorders;Current Pharmaceutical Biotechnology;2021-09-02

3. A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea;Gastroenterology Clinics of North America;2021-06

4. Fidaxomicin;Reference Module in Biomedical Sciences;2021

5. Update on Treatment of Clostridioides difficile Infection;Mayo Clinic Proceedings;2020-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3